Histological detection of catalytic ferrous iron with the selective turn-on fluorescent probe RhoNox-1 in a Fenton reaction-based rat renal carcinogenesis model

Free Radical Research

Volumn 48, Issue 9, 2014, Pages 990-995

  Mukaide, T ^a   Hattori, Y ^a   Misawa, N ^a   Funahashi, S ^a   Jiang, L ^a   Hirayama, T ^b   Nagasawa, H ^b   Toyokuni, S ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Catalytic ferrous iron; Fluorescent probe; Kidney; Morphometry; Oxidative stress

Indexed keywords

FERROUS ION; FLUORESCENT DYE; HYDROXYL RADICAL; NITRILOTRIACETATE IRON; RHONOX 1; UNCLASSIFIED DRUG; FENTON'S REAGENT; HYDROGEN PEROXIDE; IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER MODEL; CHEMICAL CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; FENTON REACTION; FROZEN SECTION; HISTOLOGY; IRON OVERLOAD; KIDNEY CANCER; KIDNEY CARCINOGENESIS; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE NECROSIS; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; CARCINOGENESIS; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; KIDNEY TUMOR; WISTAR RAT;

ANIMALS; CARCINOGENESIS; DISEASE MODELS, ANIMAL; FERROUS COMPOUNDS; FLUORESCENT DYES; HYDROGEN PEROXIDE; IRON; KIDNEY NEOPLASMS; MALE; RATS; RATS, WISTAR;

EID: 84906061681     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2014.898844     Document Type: Conference Paper

References (31)

1. Wriggleworth JM, Baum H. The biochemical function of iron. In: Jacobs A, Worwood M (eds.). Iron in biochemistry and medicine, II. London: Academic Press 1980. pp. 29-86
2. Weinberg ED. The hazards of iron loading. Metallomics 2010 2 732-740
3. Toyokuni S. Iron as a target of chemoprevention for longevity in humans. Free Radic Res 2011; 45: 906-917
4. Weinberg ED. Iron availability and infection. Biochim Biophys Acta 2009 1790 600-605
5. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: Regulation of Mammalian iron metabolism. Cell 2010 142 24-38
6. Weinberg ED. The role of iron in cancer. Eur J Cancer Prev 1996 5 19-36
7. Toyokuni S. Iron-induced carcinogenesis: The role of redox regulation. Free Radic Biol Med 1996; 20: 553-566
8. Toyokuni S. Role of iron in carcinogenesis: Cancer as a ferrotoxic disease. Cancer Sci 2009 100 9-16
9. Yuan XM. Apoptotic macrophage-derived foam cells of human atheromas are rich in iron and ferritin, suggesting ironcatalysed reactions to be involved in apoptosis. Free Radic Res 1999 30 221-231
10. Rowley D, Gutteridge JM, Blake D, Farr M, Halliwell B. Lipid peroxidation in rheumatoid arthritis: Thiobarbituric acid-reactive material and catalytic iron salts in synovial fl uid from rheumatoid patients. Clin Sci (Lond) 1984; 66: 691-695
11. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. New York: Oxford University Press 2007
12. Fenton HJH. Oxidation of tartaric acid in presence of iron. J Chem Soc 1894 65 899-910
13. Hirayama T, Okuda K, Nagasawa H. A highly selective turn-on fl uorescent probe fro iron(II) to visualize labile iron in living cells. Chem Sci 2013 4 1250-1256
14. Ebina Y, Okada S, Hamazaki S, Ogino F, Li JL, Midorikawa O. Nephrotoxicity and renal cell carcinoma after use of ironand aluminum-nitrilotriacetate complexes in rats. J Natl Cancer Inst 1986 76 107-113
15. Toyokuni S, Uchida K, Okamoto K, Hattori-Nakakuki Y, Hiai H, Stadtman ER. Formation of 4-hydroxy-2-nonenalmodifi ed proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 1994 91 2616-2620
16. Toyokuni S, Mori T, Dizdaroglu M. DNA base modifi cations in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Int J Cancer 1994 57 123-128
17. Nishiyama Y, Suwa H, Okamoto K, Fukumoto M, Hiai H, Toyokuni S. Low incidence of point mutations in H-, Kand N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Jpn J Cancer Res 1995 86 1150-1158
18. Toyokuni S, Luo XP, Tanaka T, Uchida K, Hiai H, Lehotay DC. Induction of a wide range of C2-12 aldehydes and C7-12 acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic Biol Med 1997 22 1019-1027
19. Akatsuka S, Yamashita Y, Ohara H, Liu YT, Izumiya M, Abe K, et al. Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer. PLoS ONE 2012 7 e43403
20. Tanaka T, Nishiyama Y, Okada K, Hirota K, Matsui M, Yodoi J, et al. Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: Independence of tubular necrosis and sulfhydryl depletion. Lab Invest 1997 77 145-155
21. Toyokuni S, Sagripanti JL. Iron-mediated DNA damage: Sensitive detection of DNA strand breakage catalyzed by iron. J Inorg Biochem 1992 47 241-248
22. Toyokuni S, Sagripanti J-L. DNA single- And double-strand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis. Carcinogenesis 1993; 14: 223-227
23. Toyokuni S, Sagripanti JL. Iron chelators modulate the production of DNA strand breaks and 8- hydroxy-2 -deoxyguanosine. Free Radic Res 1999; 31: 123-128
24. Toyokuni S, Okada S, Hamazaki S, Minamiyama Y, Yamada Y, Liang P, et al. Combined histochemical and biochemical analysis of sex hormone dependence of ferric nitrilotriacetate-induced renal lipid peroxidation in DdY mice. Cancer Res 1990 50 5574-5580
25. Okada S, Minamiyama Y, Hamazaki S, Toyokuni S, Sotomatsu A. Glutathione cycle dependency of ferric nitrilotriacetate-induced lipid peroxidation in mouse proximal renal tubules. Arch Biochem Biophys 1993 301 138-142
26. Kawai Y, Furuhata A, Toyokuni S, Aratani Y, Uchida K. Formation of acrolein-derived 2 -deoxyadenosine adduct in an iron-induced carcinogenesis model. J Biol Chem 2003 278 50346-50354
27. Veuthey T, Hoff man D, Vaidya VS, Wessling-Resnick M. Impaired renal function and development in Belgrade rats. Am J Physiol Renal Physiol 2014 306 F333-343
28. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2 -deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997; 387: 147-163
29. Uchida K. 4-Hydroxy-2-nonenal: A product and mediator of oxidative stress. Prog Lipid Res 2003 42 318-343
30. Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Ochi H, Hiai H, et al. Quantitative immunohistochemical determination of 8-hydroxy-2 -deoxyguanosine by a monoclonal antibody N45.1: Its application to ferric nitrilotriacetate- induced renal carcinogenesis model. Lab Invest 1997; 76: 365-374
31. Toyokuni S, Miyake N, Hiai H, Hagiwara M, Kawakishi S, Osawa T, Uchida K. The monoclonal antibody specifi c for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett 1995 359 189-191.